190 related articles for article (PubMed ID: 35663436)
1. Objective ambulatory pH monitoring and subjective symptom assessment of gastroesophageal reflux disease show type of carbohydrate and type of fat matter.
Gu C; Olszewski T; Vaezi MF; Niswender KD; Silver HJ
Therap Adv Gastroenterol; 2022; 15():17562848221101289. PubMed ID: 35663436
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Modifying Amount and Type of Dietary Carbohydrate on Esophageal Acid Exposure Time and Esophageal Reflux Symptoms: A Randomized Controlled Trial.
Gu C; Olszewski T; King KL; Vaezi MF; Niswender KD; Silver HJ
Am J Gastroenterol; 2022 Oct; 117(10):1655-1667. PubMed ID: 35973185
[TBL] [Abstract][Full Text] [Related]
3. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
4. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
Triadafilopoulos G; Kamal A; Clarke JO
Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
[TBL] [Abstract][Full Text] [Related]
5. Association of serum gastric inhibitory polypeptide and pancreatic polypeptide levels with prolonged esophageal acid exposure time in refractory gastroesophageal reflux disease.
Chen J; Guo B; Guo Z; Li L; Jiang J; Zhan Y; Wu J; Zhang C
Medicine (Baltimore); 2019 Jun; 98(23):e15965. PubMed ID: 31169725
[TBL] [Abstract][Full Text] [Related]
6. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
[TBL] [Abstract][Full Text] [Related]
7. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
8. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
9. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R; Gyawali CP; Pandolfino JE;
Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
11. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
12. Acid Exposure Time > 6% Might Not Improve the Therapeutic Outcome in Chinese Gastroesophageal Reflux Disease Patients.
Lin Y; Li Y; Liang M; Tan N; Zhang M; Chen S; Xiao Y
J Neurogastroenterol Motil; 2021 Jan; 27(1):55-62. PubMed ID: 32699186
[TBL] [Abstract][Full Text] [Related]
13. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.
Kushnir VM; Sayuk GS; Gyawali CP
Am J Gastroenterol; 2010 May; 105(5):1032-8. PubMed ID: 19920808
[TBL] [Abstract][Full Text] [Related]
14. Belching: dyspepsia or gastroesophageal reflux disease?
Lin M; Triadafilopoulos G
Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
[TBL] [Abstract][Full Text] [Related]
15. Lemborexant Attenuates Regurgitation without Worsening Objective Parameters on Reflux Monitoring in Patients with Gastroesophageal Reflux Disease and Insomnia: A Single-Arm Proof-of-Concept Study.
Hoshikawa Y; Momma E; Kawami N; Iwakiri K
Digestion; 2023; 104(6):438-445. PubMed ID: 37429270
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of diagnosing gastroesophageal reflux disease by GerdQ, esophageal impedance monitoring and histology.
Zhou LY; Wang Y; Lu JJ; Lin L; Cui RL; Zhang HJ; Xue Y; Ding SG; Lin SR
J Dig Dis; 2014 May; 15(5):230-8. PubMed ID: 24528678
[TBL] [Abstract][Full Text] [Related]
17. Hiatal hernias associated with acid reflux: size larger than 2 cm matters.
Shahsavari D; Smith MS; Malik Z; Parkman HP
Dis Esophagus; 2022 Aug; 35(8):. PubMed ID: 35066592
[TBL] [Abstract][Full Text] [Related]
18. Beverage intake among preschool children and its effect on weight status.
O'Connor TM; Yang SJ; Nicklas TA
Pediatrics; 2006 Oct; 118(4):e1010-8. PubMed ID: 17015497
[TBL] [Abstract][Full Text] [Related]
19. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
Roorda AK; Marcus SN; Triadafilopoulos G
Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
